Fighting antibiotic resistance with new treatments

Marc Torrent

Universitat Autònoma de Barcelona (UAB), Barcelona, Spain

Antibiotic resistance represents one of the most pressing health challenges of modern times. Each year, infections caused by bacteria resistant to standard antibiotics result in hundreds of thousands of deaths globally. These bacteria, particularly those with strong outer barriers, are notoriously difficult to treat. Current treatments often involve potent drugs that target not only the harmful pathogens but also the beneficial bacteria within the human body, leading to further health complications.

This project is dedicated to developing a new class of antibiotics that are both precise and safe for the body. The approach focuses on a system that is essential for the survival of pathogens, but is absent in the beneficial bacteria necessary for maintaining human health. By targeting this unique system, the project aims to develop therapies that effectively combat dangerous infections while preserving the body's natural balance.

Significant progress has already been achieved. Researchers are now working to understand how these compounds function, testing their efficacy against various bacterial strains, and refining their properties to ensure patient safety. This innovative strategy has the potential to reduce global mortality rates, shorten hospital stays, and lower healthcare expenses.

If successful, these efforts could lead to a new generation of antibiotics that not only treat infections caused by resistant bacteria but also preserve the beneficial bacteria within the body. Such advancements would mark a major milestone in addressing antibiotic resistance, offering improved patient outcomes and helping solve a critical public health crisis.

Next-Generation Antimicrobials: A Precision Medicine Approach to Gram-Negative Infections

Stage 1